These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27697759)

  • 21. Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study.
    Liu SW; Chang HJ; Chia JH; Kuo AJ; Wu TL; Lee MH
    J Microbiol Immunol Infect; 2012 Apr; 45(2):113-9. PubMed ID: 22154994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tigecycline resistance among Klebsiella pneumoniae isolated from febrile neutropenic patients.
    Elgendy SG; Abdel Hameed MR; El-Mokhtar MA
    J Med Microbiol; 2018 Jul; 67(7):972-975. PubMed ID: 29799385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline.
    Hentschke M; Wolters M; Sobottka I; Rohde H; Aepfelbacher M
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2720-3. PubMed ID: 20350947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae.
    Ruzin A; Visalli MA; Keeney D; Bradford PA
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1017-22. PubMed ID: 15728897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IS5 element integration, a novel mechanism for rapid in vivo emergence of tigecycline nonsusceptibility in Klebsiella pneumoniae.
    Nielsen LE; Snesrud EC; Onmus-Leone F; Kwak YI; Avilés R; Steele ED; Sutter DE; Waterman PE; Lesho EP
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6151-6. PubMed ID: 25092708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: Role of the global regulator RamA and its local repressor RamR.
    Wang X; Chen H; Zhang Y; Wang Q; Zhao C; Li H; He W; Zhang F; Wang Z; Li S; Wang H
    Int J Antimicrob Agents; 2015 Jun; 45(6):635-40. PubMed ID: 25681067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of tigecycline-resistant Klebsiella pneumoniae ST11 clone in patients without exposure to tigecycline.
    Goodarzi R; Arabestani M; Alikhani MY; Keramat F; Asghari B
    J Infect Dev Ctries; 2021 Nov; 15(11):1677-1684. PubMed ID: 34898496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae.
    Yuhan Y; Ziyun Y; Yongbo Z; Fuqiang L; Qinghua Z
    Rev Soc Bras Med Trop; 2016 Apr; 49(2):165-71. PubMed ID: 27192584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.
    Machuca I; Gutiérrez-Gutiérrez B; Gracia-Ahufinger I; Rivera Espinar F; Cano Á; Guzmán-Puche J; Pérez-Nadales E; Natera C; Rodríguez M; León R; Castón JJ; Rodríguez-López F; Rodríguez-Baño J; Torre-Cisneros J
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.
    Endimiani A; Patel G; Hujer KM; Swaminathan M; Perez F; Rice LB; Jacobs MR; Bonomo RA
    Antimicrob Agents Chemother; 2010 Jan; 54(1):526-9. PubMed ID: 19901089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
    Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
    J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes.
    Chiu SK; Chan MC; Huang LY; Lin YT; Lin JC; Lu PL; Siu LK; Chang FY; Yeh KM
    PLoS One; 2017; 12(4):e0175140. PubMed ID: 28388651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae.
    van Duin D; Cober E; Richter SS; Perez F; Kalayjian RC; Salata RA; Evans S; Fowler VG; Bonomo RA; Kaye KS
    Infect Control Hosp Epidemiol; 2015 Aug; 36(8):942-8. PubMed ID: 25990806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular analysis of the ramRA locus in clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline.
    Campos CB; Aepfelbacher M; Hentschke M
    New Microbiol; 2017 Apr; 40(2):135-138. PubMed ID: 28368073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta--lactamase-producing Klebsiella pneumoniae epidemic clone.
    Cobo J; Morosini MI; Pintado V; Tato M; Samaranch N; Baquero F; Cantón R
    Diagn Microbiol Infect Dis; 2008 Mar; 60(3):319-22. PubMed ID: 17996417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae.
    Nigo M; Cevallos CS; Woods K; Flores VM; Francis G; Perlman DC; Revuelta M; Mildvan D; Waldron M; Gomez T; Koshy S; Jodlowski T; Riley W; Ruhe JJ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5743-6. PubMed ID: 23979745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
    Neuner EA; Yeh JY; Hall GS; Sekeres J; Endimiani A; Bonomo RA; Shrestha NK; Fraser TG; van Duin D
    Diagn Microbiol Infect Dis; 2011 Apr; 69(4):357-62. PubMed ID: 21396529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo development of tigecycline resistance in Klebsiella pneumoniae owing to deletion of the ramR ribosomal binding site.
    Ye M; Ding B; Qian H; Xu Q; Jiang J; Huang J; Ou H; Hu F; Wang M
    Int J Antimicrob Agents; 2017 Oct; 50(4):523-528. PubMed ID: 28668690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens.
    Qureshi ZA; Paterson DL; Potoski BA; Kilayko MC; Sandovsky G; Sordillo E; Polsky B; Adams-Haduch JM; Doi Y
    Antimicrob Agents Chemother; 2012 Apr; 56(4):2108-13. PubMed ID: 22252816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
    Rodríguez-Avial C; Rodríguez-Avial I; Merino P; Picazo JJ
    Clin Microbiol Infect; 2012 Jan; 18(1):61-6. PubMed ID: 21722259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.